http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0173419-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d00b02f845cc4d1e9ff04196a105ccf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37235
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36021
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
filingDate 1985-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50439bae84d439abd5735a6caf04d439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c2e7b3f17133b494306ad83c90fb672
publicationDate 1986-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0173419-A1
titleOfInvention Transcutaneous nerve stimulation device using a common controller for pulse production and parameter display
abstract @ A transcutaneous nerve stimulation device is provided using a common controller (10) for both output pulse production and treatment parameter display. The common controller, which preferentially takes the form of a programmed microprocessor (10) is connected by signal lines to both the pulse output circuitry and the display, which are controlled by time-sharing the signal lines. The controller (10) is responsive to operator entered input signals for the calculation of output pulse characteristics and display parameters. During a majority of treatment time, the controller (10) is providing signals on the signal lines for control of the display. The display signals are interrupted during timed intervals when output signals are produced.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101428165-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0270829-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0270828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3248583-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0298268-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9219155-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792495-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0288234-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0288234-A2
priorityDate 1984-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2264024-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6083

Total number of triples: 28.